✦ LIBER ✦

775 Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2B and ribavirin combination

✍ Scribed by Jerome Dumortier; Jean-Yves Scoazec; Philippe Chevallier; Olivier Boillot

Book ID: 119530681
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 136 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80817-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of recurrent hepatitis C after

Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination

✍ Jérôme Dumortier; Jean-Yves Scoazec; Philippe Chevallier; Olivier Boillot 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 225 KB

768 Treatment of recurrent hepatitis C a

768 Treatment of recurrent hepatitis C after liver transplantation with peginterferon alfa-2B and ribavirin

✍ Ulf P. Neumann; Jan M. Langrehr; Thomas Berg; Peter Neuhaus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Pilot study of pegylated interferon alfa

Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation

✍ S Mukherjee; J Rogge; L Weaver; D.F Schafer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Pilot study of pegylated interferon alfa

Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation

✍ Sandeep Mukherjee; Richard K. Gilroy; Joyce Rogge; Lynne Weaver; Timothy M. McCa 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Plasma ribavirin concentrations during t

Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon α-2b and ribavirin combination after liver transplantation

✍ J. Dumortier; E. Ducos; J.-Y. Scoazec; P. Chevallier; O. Boillot; M.-C. Gagnieu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Pilot study of the combination of interf

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation

✍ T Bizollon; U Palazzo; C Ducerf; M Chevallier; M Elliott; J Baulieux; M Pouyet; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

Recurrent hepatitis C virus (HCV) in liver transplant patients is a major cause of graft loss, liver failure, and need for retransplantation. The results available to date with the use of interferon alfa (IFN-alpha) in the treatment of recurrent HCV in liver transplant patients have been disappointi